Anti-IL5RA重组抗体|科研级 Benralizumab ( 苯拉组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-IL5RA重组抗体|科研级 Benralizumab ( 苯拉组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-IL5RA重组抗体|科研级 Benralizumab ( 苯拉组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1226

Alias

科研级 Benralizumab ( 苯拉组单抗 ), Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab

Molecular Name

Benralizumab

Size

1mg, 5mg

CAS Number

1044511-01-4

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

WB, FC, IP, ELISA, Neut, FuncS, IF

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6492H10060N1724O2028S42

Target

IL5RA/CD12[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ